Session Details
 DV9185 - What PAs Need to Know About HIV Prevention and Preexposure Prophylaxis (PrEP)
Tuesday, May 21, 2019
03:00 PM - 04:00 PM
$0     CME 
Location: 111
Description:
CME NUMBER: DV9185
Over 35,000 HIV infections occur annually in the U.S. despite widespread availability of condoms and programs directed at behavioral change. HIV Prevention changed largely with: 1) FDA approval of the combination antiretroviral (ARV) Truvada (tenofovir/emtricitabine) for HIV prevention in high risk individuals as preexposure prophylaxis (PrEP); and 2) Increased evidence of treatment as prevention where use of antiretrovirals by HIV-infected individuals nearly eliminates risk of HIV sexual transmission. PAs must become familiar with these medications to counsel patients on indication, use, and side effect profile alongside the more established methods of HIV prevention including condom use and behavioral change. Familiarity with these medications and options for HIV prevention will allow patients and PAs to make appropriate choices when creating a patient-centered prevention plan.

At the end of this session, participants should be able to:
• Identify risk factors for HIV among their patients
• Recognize biomedical HIV prevention methods including PrEP, PEP, and treatment as prevention
• Reference current guidelines for the use of ARVs as prevention
• Discuss how biomedical HIV prevention can be tailored as part of patient-centered care


PHARMACOLOGY
AAPA CONFERENCE ON DEMAND

Speaker(s):
CME Track(s):
Name
INFD - Infectious Disease/HIV
PREV - Preventive Medicine
DIVR - Disparities/Diversity